2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Larynx: new trials by email Literature Review of Larynx trials Research Report on Larynx
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN Durvalumab, Intensity Modulated Radiotherapy Treatments - Larynx, Lip | Phase 2 | Completed | UNC Lineberger Comprehensive Cancer Center | 18 | 2019-10-07 | 2026-10-22 |
| A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN Low dose fractionated radiation - 80cGy with chemotherapy, Docetaxel and Carboplatin AUC 6 - Head and Neck Cancer, Larynx | Phase 2 | Completed | Susanne Arnold | 45 | 2014-10-01 | 2023-03-13 |
Laryngeal Diseases (2) · Head and Neck Neoplasms (1) · Lymphoid Interstitial Pneumonia (1) · Mouth Neoplasms (1) · Neoplasms (1)
Neoplasms by Site (2) · Otorhinolaryngologic Diseases (2) · Respiratory Tract Diseases (2) · Head and Neck Neoplasms (1) · Mouth Diseases (1) · Neoplasms (1) · Stomatognathic Diseases (1)
Docetaxel (1) · Drug Therapy (1) · durvalumab (1)
Susanne Arnold (1) · UNC Lineberger Comprehensive Cancer Center (1)
United States (2)
Siddharth Sheth, DO MPH (1) · Susanne M Arnold, MD (1)